Skip to main content
Fig. 2 | BMC Cancer

Fig. 2

From: Assessing tumor angiogenesis using dynamic contrast-enhanced integrated magnetic resonance-positron emission tomography in patients with non-small-cell lung cancer

Fig. 2

Comparisons of serum VEGF-A, angiogenin, and angiopoietin-1 concentrations between non-small-cell lung carcinoma (NSCLC) patients and healthy controls. Serum (a) VEGF-A, (b) angiogenin, and (c) angiopoietin-1 concentrations in patients and healthy controls. P-values for statistical comparisons were obtained using the unpaired Student’s t-test

Back to article page